TIAA CREF Investment Management’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-153
Closed – – 3149
2017
Q2
$0 Hold
153
– – ﹤0.01% 3277
2017
Q1
$0 Hold
153
– – ﹤0.01% 3143
2016
Q4
$0 Hold
153
– – ﹤0.01% 3164
2016
Q3
$0 Sell
153
-186
-55% -$51 ﹤0.01% 3171
2016
Q2
$0 Buy
+339
New +$177 ﹤0.01% 3290

TIAA CREF Investment Management's AST.WS Position: Q3 2017 in Review

TIAA CREF Investment Management sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 153 shares.

TIAA CREF Investment Management first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • TIAA CREF Investment Management reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 153 Asterias Biotherapeutics Warrants shares in Q3 2017.
  • TIAA CREF Investment Management first reported a position in Asterias Biotherapeutics Warrants in Q2 2016 and held it in 5 quarters.
  • TIAA CREF Investment Management's Asterias Biotherapeutics Warrants position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.

Based on TIAA CREF Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.